Advances in MS Treatment

preview_player
Показать описание
Dr. Lucas McCarthy discusses a newly approved treatment for both relapsing and primary progressive forms of MS called Ocrevus (Ocrelizumab) along with other advances and research goals for MS treatment. Ocrevus was approved by the FDA on March 2017 and is an intravenous infusion therapy used to prevent MS relapses and slow disease progression.
Рекомендации по теме
Комментарии
Автор

This doctor saw me and he didn’t do any further test on me, didn’t even try reading
my doctors notes and diagnosed me with fibromyalgia. I literally cried in the elevator due to his dismissal.

TheCriscantu